Qilian International Holding Group Limited (BGM) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $0.26 (+2.01%), Market cap $0.06B, 52-week low–high $0.26 ~ $16.36.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and
Financial statements, price targets, institutional (13F) holdings and related news for Qilian International Holding Group Limited are updated in real time on BlackAll Trade.
Qilian International Holding Group Limited trades at $0.26 (+2.01%). Real-time quotes and charts are available on BlackAll Trade.
Qilian International Holding Group Limited has a market cap of about $0.06B.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and t